Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain bleed drug doses vary widely – new study aims to fix that

NCT ID NCT07065903

First seen Feb 10, 2026 · Last updated May 21, 2026 · Updated 12 times

Summary

This study looks at how much nimodipine, the only proven drug for brain aneurysm bleeds, actually gets into patients' blood. Researchers will measure drug levels in 500 adults across Canada and the US and check their recovery 90 days later. The goal is to understand why some patients get less benefit and to pave the way for personalized dosing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBARACHNOID HEMORRHAGE, ANEURYSMAL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Health Network - Toronto Western Hospital

    RECRUITING

    Toronto, Ontario, M5T 2S8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Alberta Hospital

    RECRUITING

    Edmonton, Alberta, T6G 2X8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • VCU Medical Center

    RECRUITING

    Richmond, Virginia, 23219, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.